Skye Bioscience, Inc. (SKYE)

Skye Bioscience Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	99	86	34	15	25	11
Market Cap Growth	-42.39%	155.60%	126.97%	-40.22%	130.88%	-42.17%
Enterprise Value	49	19	33	17	16	8
Last Close Price	3.14	2.83	2.72	4.05	13.00	10.00
PB Ratio	2.23	1.26	-15.76	-4.92	4.22	23.79
P/TBV Ratio	2.23	1.26	-	-	4.22	23.79
Debt / Equity Ratio	0.01	0.01	-2.16	-0.66	0.36	3.32
Quick Ratio	5.85	15.77	0.14	0.12	2.30	3.14
Current Ratio	6.09	16.32	0.84	0.74	2.46	3.39
Return on Equity (ROE)	-72.75%	-80.48%	-	-1364.20%	-269.91%	-1313.66%
Return on Assets (ROA)	-40.92%	-44.56%	-80.28%	-120.69%	-78.31%	-168.39%
Return on Capital (ROIC)	-46.79%	-53.09%	-1159.18%	-328.19%	-98.60%	-272.61%
Earnings Yield	-43.55%	-30.94%	-112.07%	-131.64%	-34.42%	-61.18%
FCF Yield	-35.91%	-31.26%	-41.57%	-86.75%	-26.52%	-56.53%
Buyback Yield / Dilution	-82.20%	-420.79%	-215.43%	-36.56%	-75.70%	-36.48%

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q